Canada Pension Plan Investment Board’s ANI Pharmaceuticals ANIP Stock Holding History

Canada Pension Plan Investment Board’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$546K	Sell	6,600 -100	-1%	-$8.02K	﹤0.01%	1238
2026 Q1	$515K	Sell	6,700 -6,200	-48%	-$484K	﹤0.01%	1225
2025 Q4	$1.02M	Buy	12,900 +6,900	+115%	+$597K	﹤0.01%	1064
2025 Q3	$550K	Sell	6,000 -1,600	-21%	-$130K	﹤0.01%	1036
2025 Q2	$496K	Buy	7,600 +3,600	+90%	+$234K	﹤0.01%	1021
2025 Q1	$268K	Sell	4,000 -26,700	-87%	-$1.59M	﹤0.01%	1018
2024 Q4	$1.7M	Buy	+30,700	New	+$1.76M	﹤0.01%	911

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Canada Pension Plan Investment Board's ANIP Position: Q2 2026 in Review

Canada Pension Plan Investment Board reduced its ANI Pharmaceuticals (ANIP) stake by 1.5% in Q2 2026, selling an estimated $8.02K and leaving 6,600 shares worth $546K. The position accounts for ﹤0.01% of the portfolio, ranked #1238.

Canada Pension Plan Investment Board first reported a position in ANIP in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.7M in Q4 2024. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

Canada Pension Plan Investment Board held 6,600 shares of ANI Pharmaceuticals worth $546K as of Q2 2026.
Canada Pension Plan Investment Board sold 100 ANI Pharmaceuticals shares in Q2 2026, an estimated $8.02K.
ANI Pharmaceuticals made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1238 holding.
Canada Pension Plan Investment Board first reported a position in ANI Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
Canada Pension Plan Investment Board's ANI Pharmaceuticals position peaked at $1.7M in Q4 2024.
307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.